Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

Hepatology International

Volumn 3, Issue 4, 2009, Pages 556-562

  Miyake, Yasuhiro ^a   Iwasaki, Yoshiaki ^a   Kobashi, Haruhiko ^a   Yasunaka, Tetsuya ^a   Ikeda, Fusao ^a   Takaki, Akinobu ^a   Okamoto, Ryoichi ^b   Takaguchi, Kouichi ^c   Ikeda, Hiroshi ^d   Makino, Yasuhiro ^e   Ando, Masaharu ^f   Sakaguchi, Kohsaku ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b HIROSHIMA CITY HOSPITAL   (Japan)

^c KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d KURASHIKI CENTRAL HOSPITAL   (Japan)

^e IWAKUNI NATIONAL HOSPITAL   (Japan)

^f Japan   (Japan)

Author keywords

Autoimmune hepatitis; Corticosteroid; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CORTICOSTEROID; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G; PREDNISOLONE; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIVER BIOPSY; LIVER FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 73349142669     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-009-9155-9     Document Type: Article

References (18)

1. EL Krawitt 2006 Autoimmune hepatitis N Engl J Med 354 54 66 10.1056/NEJMra050408 1:CAS:528:DC%2BD28XhvV2qug%3D%3D 16394302 (Pubitemid 43048951)
2. G Toda M Zeniya F Watanabe M Imawari K Kiyosawa M Nishioka, et al. 1997 Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis J Hepatol 26 1207 1212 10.1016/S0168-8278(97)80453-9 1:STN:280:DyaK2szlsVeisw%3D%3D 9210605 (Pubitemid 27346631)
3. AJ Czaja HA Carpenter 2004 Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis J Hepatol 40 646 652 10.1016/j.jhep.2004.01.009 1:CAS:528:DC%2BD2cXitFKhsLg%3D 15030981 (Pubitemid 38367787)
4. SK Roberts TM Therneau AJ Czaja 1996 Prognosis of histological cirrhosis in type 1 autoimmune hepatitis Gastroenterology 110 848 857 10.1053/gast.1996. v110.pm8608895 1:STN:280:DyaK287nslOguw%3D%3D 8608895 (Pubitemid 26071852)
5. AJ Montano-Loza HA Carpenter AJ Czaja 2007 Consequences of treatment withdrawal in type 1 autoimmune hepatitis Liver Int 27 507 515 10.1111/j.1478-3231.2007.01444.x 1:CAS:528:DC%2BD2sXlvFyksb0%3D 17403191 (Pubitemid 46534573)
6. K Nakamura M Yoneda S Yokohama K Tamori Y Sato K Aso, et al. 1998 Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis J Gastroenterol Hepatol 13 490 495 10.1111/j.1440-1746.1998.tb00674.x 1:CAS:528:DyaK1cXktVCjt7g%3D 9641646
7. U Beuers 2006 Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis Nat Clin Pract Gastroenterol Hepatol 3 318 328 10.1038/ncpgasthep0521 1:CAS:528:DC%2BD28XmtVOrsrY%3D 16741551 (Pubitemid 43842248)
8. AJ Czaja HA Carpenter KD Lindor 1999 Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial Hepatology 30 1381 1386 10.1002/hep.510300603 1:CAS:528:DC%2BD3cXktVWj 10573515
9. F Alvarez PA Berg FB Bianchi L Bianchi AK Burroughs EL Cancado, et al. 1999 International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 929 938 10.1016/S0168-8278(99) 80297-9 1:STN:280:DC%2BD3c%2Fks1Ggug%3D%3D 10580593 (Pubitemid 29514229)
10. VJ Desmet M Gerber JH Hoofnagle M Manns PJ Scheuer 1994 Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1513 1520 10.1002/hep.1840190629 1:STN:280:DyaK2c3ksFWisw%3D%3D 8188183
11. M Yoshikawa T Tsujii K Matsumura J Yamao Y Matsumura R Kubo, et al. 1992 Immunomodulatory effects of ursodeoxycholic acid on immune responses Hepatology 16 358 364 10.1002/hep.1840160213 1:STN:280:DyaK38zkslyjsA%3D%3D 1639344
12. K Ishizaki T Iwaki S Kinoshita M Koyama A Fukunari H Tanaka, et al. 2008 Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production Eur J Pharmacol 578 57 64 10.1016/j.ejphar. 2007.08.031 1:CAS:528:DC%2BD2sXhtlyrtrzJ 17888421 (Pubitemid 350179748)
13. G Maggiore F De Benedetti M Massa P Pignatti A Martini 1995 Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis J Pediatr Gastroenterol Nutr 20 23 27 1:STN:280:DyaK2M7ptVOitg%3D%3D 7884614
14. M Durazzo G Niro A Premoli E Morello ER Rizzotto R Gambino, et al. 2009 Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression? J Gastroenterol 44 476 482 10.1007/s00535-009-0023-0 1:CAS:528:DC%2BD1MXlslCrsbw%3D 19301087
15. AC Cherñavsky N Paladino AE Rubio MB De Biasio N Periolo M Cuarterolo, et al. 2004 Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children Hum Immunol 65 683 691 10.1016/j.humimm.2004.03.004 15301856 (Pubitemid 39061164)
16. Y Miyake Y Iwasaki R Terada S Takagi R Okamaoto H Ikeda, et al. 2005 Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis J Hepatol 43 951 957 10.1016/j.jhep.2005.06.006 1:CAS:528:DC%2BD2MXht1egsrnJ 16143423 (Pubitemid 41627979)
17. Y Miyake Y Iwasaki R Terada R Okamaoto H Ikeda Y Makino, et al. 2006 Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis Aliment Pharmacol Ther 24 1197 1205 10.1111/j.1365-2036.2006.03113.x 1:CAS:528:DC%2BD28Xht1WntLjP 17014578 (Pubitemid 44427507)
18. AJ Czaja DK Freese American Association for the Study of Liver Disease 2002 Diagnosis and treatment of autoimmune hepatitis Hepatology 36 479 497 10.1053/jhep.2002.34944 12143059 (Pubitemid 34810370)